Topline
Elon Musk’s Neuralink has received FDA approval to begin its “first-in-human clinical study”, the company said Thursday, a key step for the company which is attempting to develop a direct interface between the human brain and computers.
Key Facts
In an announcement on Twitter, the company said the approval was a result of the Neuralink team working in “close collaboration with the FDA.”
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased